首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2048351

維生素B4市場－全球產業規模、佔有率、趨勢、機會、預測：銷售管道、最終用途、地區和競爭格局（2021-2031年）

Vitamin B4 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Animal Feed, Food Industry, Pharmaceutical, Others), By Region & Competition, 2021-2031F

出版日期: 2026年05月25日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球維生素 B4 市場預計將從 2025 年的 7.8902 億美元成長到 2031 年的 10.0587 億美元，複合年成長率為 4.13%。

維生素B4，化學名稱為腺嘌呤，是一種重要的嘌呤鹼，對蛋白質合成和細胞內能量轉移至關重要，是DNA、RNA和ATP的核心組成部分。其市場主要受以下兩方面驅動：一是製藥業對高純度腺嘌呤的需求不斷成長，用於抗病毒和免疫抑制療法；二是動物營養行業將其用作飼料添加劑，以促進牲畜的免疫力和生長。這些應用源自於人類和動物高效代謝功能的特定工業和醫療需求，而非一般的健康趨勢。然而，由於原物料價格波動和供應鏈複雜，市場擴張面臨巨大挑戰，導致生產商和終端用戶都面臨價格不穩定的問題。儘管如此，下游消費依然強勁。例如，根據中國飼料工業協會的數據，2025年上半年中國工業飼料產量年增7.7%。雖然這項數據證實了強勁的需求，但投入成本的不確定性仍然阻礙著市場的持續成長。

市場概覽
預測期	2027-2031
市場規模：2025年	7.8902億美元
市場規模：2031年	1,005,870,000 美元
複合年成長率：2026-2031年	4.13%
成長最快的細分市場	直接地
最大的市場	北美洲

市場促進因素

全球維生素B4市場的主要促進因素是腺嘌呤作為飼料添加劑在維持牲畜健康方面的應用日益廣泛。腺嘌呤是一種重要的嘌呤鹼，正被擴大添加到飼料預混合料中，以增強家禽和豬的免疫功能並最佳化代謝能量轉移，從而直接滿足產業對高效蛋白質轉化的需求。全球畜牧業生產的復甦進一步加劇了這項需求，因為需要更多強化飼料才能達到生產目標。根據Alltech預測，2024年全球飼料產量將成長1.2%，達到13.96億噸。中國去年紅肉和禽肉總產量達9,663萬噸，也印證了這一趨勢，凸顯了對牲畜飼料的持續需求。此外，腺嘌呤作為抗病毒藥物和免疫抑制劑的前體，其在醫藥應用和治療製劑領域的拓展是另一個重要的市場促進因素。為了符合嚴格的生物製藥標準，製造商優先採購高純度維生素B4，尤其是在合成治療病毒感染疾病和慢性疾病所必需的核苷類似物方面。這種向專業藥物應用領域的策略轉變也體現在合約研發生產機構（CDMO）的財務表現中。例如，受商業性對複雜藥物活性成分的強勁需求推動，龍沙公司小分子藥物部門2024年的銷售額成長了9.3%。

市場挑戰

全球維生素B4市場穩定和成長的主要限制因素是原料成本的波動和供應鏈固有的複雜性。維生素B4生產商嚴重依賴穩定的化學前驅物供應和高能耗的合成過程來生產高純度腺嘌呤。上游投入成本的不可預測波動使得生產商難以維持穩定的定價結構，進而阻礙了他們與製藥和動物營養等下游關鍵買家簽訂長期合約的能力。這種經濟不確定性常常迫使生產商接受更低的利潤率或將增加的成本轉嫁給終端用戶，導致採購決策延遲和市場流動性降低。這些成本壓力對支撐腺嘌呤生產的整個化學製造業都產生了嚴重影響。歐洲化學工業理事會報告稱，到2025年，由於生產商難以應對比美國等競爭地區高出三倍的能源和原料成本，產能運轉率已降至74.6%。持續高漲且不穩定的營運成本阻礙了對生產能力和創新的重大投資，最終阻礙了維生素 B4 市場的整體成長軌跡。

市場趨勢

維生素B4生產方式的根本轉變正推動著永續酵素合成方法的轉型，其驅動力在於減少傳統化學製程對環境的影響和能源消耗。生產商正擴大採用生物催化系統而非傳統的化學催化劑，因為這些方法具有更高的特異性並能減少有害廢棄物的產生——這對於遵守主要產區嚴格的環境法規至關重要。這一行業轉變得益於領先的解決方案供應商（例如Novonesis）的強勁表現，該公司報告稱其2024年的有機銷售額成長了8%，凸顯了生物製造技術作為傳統化學方法的替代方案在行業中加速普及。同時，市場正明顯轉向使用腺嘌呤來提高作物對乾旱和鹽鹼等不利環境條件耐受性的非生物脅迫耐受植物生物促效劑。這一趨勢與傳統的施肥方式不同，它側重於改變植物的生理途徑以確保產量穩定，從而為維生素B4開闢了一個高價值的利基市場，使其超越了其在動物營養中的傳統作用。從主要農業科技公司的銷售表現可以看出，人們對先進農業生物產品的依賴日益加深。例如，科迪華農業科技公司（Corteva AgriScience）報告稱，2025年前九個季度農作物保護產品的銷售量成長了7%，這主要得益於全球對新型生技藥品和抗逆性管理產品的需求不斷成長。

The Global Vitamin B4 Market is projected to grow from USD 789.02 Million in 2025 to USD 1005.87 Million by 2031, exhibiting a 4.13% CAGR. Chemically identified as adenine, Vitamin B4 is a crucial purine nucleobase essential for protein synthesis and cellular energy transfer, acting as a core component of DNA, RNA, and ATP. Its market is primarily driven by demand from the expanding pharmaceutical sector for high-purity adenine in antiviral and immunosuppressive therapies, and from the animal nutrition industry, where it serves as a feed additive to enhance livestock immunity and growth. These applications stem from specific industrial and medicinal requirements for efficient metabolic function in humans and animals, rather than general wellness trends.\n\nHowever, the market's expansion faces a significant challenge due to volatile raw material costs and complex supply chains, which cause pricing instability for both manufacturers and end-users. Despite this, robust downstream consumption is evident; for example, industrial feed production in China increased by 7.7 percent in the first half of 2025 compared to the previous year, according to the China Feed Industry Association. While this data confirms strong demand, the unpredictable nature of input expenses continues to impede consistent market growth.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 789.02 Million
Market Size 2031	USD 1005.87 Million
CAGR 2026-2031	4.13%
Fastest Growing Segment	Direct
Largest Market	North America

Market Driver

A dominant force in the global Vitamin B4 market is its increasing utilization in animal feed additives for livestock health. As a vital purine nucleobase, adenine is progressively integrated into feed premixes to strengthen immune function and optimize metabolic energy transfer in poultry and swine, directly addressing the industry's need for efficient protein conversion. This demand is further amplified by the recovery in global livestock production, necessitating greater volumes of fortified feed to meet yield targets; Alltech reported a 1.2% increase in global feed production to 1.396 billion metric tons in 2024. Supporting this trend, China's total red meat and poultry production reached 96.63 million tons in the preceding year, underscoring the sustained requirement for livestock sustenance.\n\nThe expansion of pharmaceutical applications and therapeutic formulations constitutes the second critical market driver, leveraging adenine's role as a precursor for antiviral drugs and immunosuppressive agents. Manufacturers prioritize high-purity Vitamin B4 grades to adhere to stringent biopharmaceutical standards, particularly for nucleoside analog synthesis vital in treating viral infections and chronic diseases. This strategic shift towards specialized medicinal use is reflected in the financial performance of contract development and manufacturing organizations; Lonza's Small Molecules division, for instance, reported a 9.3% sales growth in 2024, driven by high commercial demand for complex active pharmaceutical ingredients.

Market Challenge

The primary impediment to the stability and growth of the Global Vitamin B4 Market is the volatility of raw material costs and the complexities inherent in supply chains. Manufacturers of Vitamin B4 are heavily dependent on a consistent supply of chemical precursors and energy-intensive synthesis processes to produce high-purity adenine. Unpredictable fluctuations in upstream input costs make it difficult for producers to maintain stable pricing structures, thereby hindering their ability to secure long-term contracts with key downstream buyers in the pharmaceutical and animal nutrition sectors. This economic uncertainty often compels manufacturers to accept reduced margins or pass increased costs onto end-users, frequently resulting in delayed procurement decisions and diminished market liquidity.\n\nThe broader chemical manufacturing sector, which underpins adenine production, illustrates the profound impact of these cost pressures. In 2025, the European Chemical Industry Council reported a drop in capacity utilization to 74.6 percent, as producers contended with energy and feedstock expenses that remained three times higher than those in competitive regions like the United States. Such consistently high and unstable operational expenditures deter crucial investments in production capacity and innovation, consequently obstructing the overall growth trajectory of the Vitamin B4 market.

Market Trends

A fundamental shift in Vitamin B4 manufacturing involves the transition toward sustainable enzymatic synthesis methods, driven by the imperative to reduce the environmental footprint and energy consumption associated with traditional chemical processes. Producers are increasingly adopting biocatalytic systems over conventional chemical catalysis, as these offer enhanced specificity and generate less hazardous waste, which is crucial for complying with strict environmental regulations in major production areas. This industrial change is supported by the robust financial performance of leading biosolution providers, such as Novonesis, which reported an 8% organic sales growth in 2024, highlighting the accelerating industry adoption of biological manufacturing technologies over older chemical methods.\n\nConcurrently, the market is observing a distinct expansion into abiotic stress-resilient plant biostimulants, where adenine is employed to improve crop tolerance against adverse environmental conditions like drought and salinity. This trend, distinct from conventional fertilizer applications, focuses on modifying plant physiological pathways to ensure yield stability, thereby carving out a high-value niche for Vitamin B4 beyond its traditional role in animal nutrition. The increasing reliance on advanced agricultural biologicals is evident in the sales volumes of major agriscience corporations; Corteva Agriscience, for instance, reported a 7% increase in crop protection sales volume during the first nine months of 2025, a growth largely attributed to the rising global demand for new biological formulations and stress-management products.

Key Market Players

Shandong Yinfeng Biological Technology Co., Ltd.
GHW International
St. Gabriel CC Company, LLC
Balchem Corporation
Jubilant Ingrevia Limited
Hangzhou Donglou Bio-Nutrition Co., Ltd.
Shandong NB Technology Co Ltd.,
Shandong Jujia Biotech Co.,Ltd
Liaoning Biochem Co., Ltd
Shandong Aocter Chemical Co.,Ltd.

Report Scope

In this report, the Global Vitamin B4 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B4 Market, By Sales Channel

Direct
Indirect

Vitamin B4 Market, By End Use

Animal Feed
Food Industry
Pharmaceutical
Others

Vitamin B4 Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B4 Market.

Available Customizations:

Global Vitamin B4 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vitamin B4 Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Sales Channel (Direct, Indirect)
- 5.2.2. By End Use (Animal Feed, Food Industry, Pharmaceutical, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Vitamin B4 Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Sales Channel
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Vitamin B4 Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Sales Channel
    - 6.3.1.2.2. By End Use
- 6.3.2. Canada Vitamin B4 Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Sales Channel
    - 6.3.2.2.2. By End Use
- 6.3.3. Mexico Vitamin B4 Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Sales Channel
    - 6.3.3.2.2. By End Use

7. Europe Vitamin B4 Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Sales Channel
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Vitamin B4 Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Sales Channel
    - 7.3.1.2.2. By End Use
- 7.3.2. France Vitamin B4 Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Sales Channel
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Vitamin B4 Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Sales Channel
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Vitamin B4 Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Sales Channel
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Vitamin B4 Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Sales Channel
    - 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B4 Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Sales Channel
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Vitamin B4 Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Sales Channel
    - 8.3.1.2.2. By End Use
- 8.3.2. India Vitamin B4 Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Sales Channel
    - 8.3.2.2.2. By End Use
- 8.3.3. Japan Vitamin B4 Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Sales Channel
    - 8.3.3.2.2. By End Use
- 8.3.4. South Korea Vitamin B4 Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Sales Channel
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Vitamin B4 Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Sales Channel
    - 8.3.5.2.2. By End Use

9. Middle East & Africa Vitamin B4 Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Sales Channel
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Vitamin B4 Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Sales Channel
    - 9.3.1.2.2. By End Use
- 9.3.2. UAE Vitamin B4 Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Sales Channel
    - 9.3.2.2.2. By End Use
- 9.3.3. South Africa Vitamin B4 Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Sales Channel
    - 9.3.3.2.2. By End Use

10. South America Vitamin B4 Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Sales Channel
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Vitamin B4 Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Sales Channel
    - 10.3.1.2.2. By End Use
- 10.3.2. Colombia Vitamin B4 Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Sales Channel
    - 10.3.2.2.2. By End Use
- 10.3.3. Argentina Vitamin B4 Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Sales Channel
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Vitamin B4 Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Shandong Yinfeng Biological Technology Co., Ltd.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. GHW International
15.3. St. Gabriel CC Company, LLC
15.4. Balchem Corporation
15.5. Jubilant Ingrevia Limited
15.6. Hangzhou Donglou Bio-Nutrition Co., Ltd.
15.7. Shandong NB Technology Co Ltd.,
15.8. Shandong Jujia Biotech Co.,Ltd
15.9. Liaoning Biochem Co., Ltd
15.10. Shandong Aocter Chemical Co.,Ltd.